Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Acceleration × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphatic Metastasis 1 Deception 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 2672 Cisplatin 2637 Carboplatin 2447 Radiotherapy 2255 Paclitaxel 2244 Gemcitabine 2114 pembrolizumab 1953 Docetaxel 1855 Bevacizumab 1765 Fluorouracil 1534 Capecitabine 1503 Oxaliplatin 1425 Dexamethasone 1327 Nivolumab 1252 Doxorubicin 1246 Rituximab 1232 Etoposide 1127 Magnetic Resonance Spectroscopy 1054 Irinotecan 1033 Leucovorin 1017 Cytarabine 964 Drug Therapy 890 fludarabine 888 Pemetrexed 883 Vincristine 792 Lenalidomide 782 Prednisone 778 Cetuximab 767 Filgrastim 763 Specimen Handling 759

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03280719 2024-09-19

PRO-SURF

University Hospital, Ghent

Phase NA Completed

Breast Neoplasms, Deception, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡